Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD)
2 other identifiers
observational
475
1 country
1
Brief Summary
Background: Alcohol use disorder (AUD) is the most common substance use disorder in the world. Long-term AUD can affect a person s sense of taste and smell. This natural history study will compare alcohol drinking behaviors and measures of taste and smell in people with and without AUD. Objective: To understand how alcohol use changes the senses of taste and smell. Eligibility: People aged 18 to 65 years with or without AUD. Design: Participants will be screened. They will have several tests to assess their smell and taste functions. They will answer questions about their eating, alcohol use, and smoking or vaping habits. Participants will have 2 study visits. They will give samples of blood, nasal mucous, saliva, stool, and urine. Their bodies will be measured. They will undergo a type of scan that uses X-rays to measure their body composition. They will complete taste measurements. They will taste liquids by swishing them in their mouth, without swallowing. Then, they will be asked what they can detect and which flavors they preferred. They will also complete smell measurements. They will be asked if they can identify strong odors on a metal wand. They will be asked to rate the intensity and pleasantness of odors. Their brain activity in the frontal regions will be measured while they smell various odors. For this, we will use a brain imaging tool called functional near infrared spectroscopy. They will have sensory testing. Sensations such as pressure, pinpricks, heat, or vibrations will be applied to their skin. Then, they will be asked what they felt. They will keep diaries. They will write down what they eat (for 3 days), the alcohol they drink (3 days), and how much they sleep (14 days). They will wear a wristwatch-like device that records their activity for 14 days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2023
CompletedFirst Posted
Study publicly available on registry
January 10, 2023
CompletedStudy Start
First participant enrolled
January 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
October 24, 2025
October 22, 2025
4 years
January 7, 2023
October 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Taste and smell measures, alcohol drinking behavior
Compare individuals with AUD to those without AUD in measures of taste and smell and alcohol drinking behaviors.
At enrollment
Secondary Outcomes (1)
Inflammatory markers, genotypes, microbiota, salivary and metabolic hormones, biological measures, and personal factors
At enrollment
Study Arms (2)
Participants with AUD
Drink regularly (i.e., 2 or more drinks per day for at least 3 days per week in the past 12 months)
Participants without AUD
Does not drink regularly (less than 2 drinks per day for at least 3 days per week in the past 12 months)
Eligibility Criteria
Participants will be recruited from the Washington D.C. area.
You may qualify if:
- To be eligible to participate in this study, an individual must meet all the following criteria:
- Individuals between 18 to 65 years of age. Although the age range of participants recruited in the NIAAA Natural History protocol is between 18-77 years, due to documented knowledge that taste and smell diminishes with age, we will limit age to this range.
- Individuals with a diagnosis of AUD (for the AUD cohort) OR without a diagnosis of AUD (for the non-AUD cohort) per clinician assessment
- Able to provide their own consent.
- Due to the extensive questionnaires (administered in English language only) that participants must complete independently, fluency in the English language is needed. Hence, participants must be able to read and understand English.
You may not qualify if:
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Diagnosis by a medical professional of morbid obesity or BMI \> 40 or renal disease.
- Any history of chronic rhinitis, eating disorder, chronic upper respiratory infection, chronic allergic rhinitis, or nasal polyps in the last 6 months of screening, or current daily use of nasal sprays.
- Altered cranial nerves associated with taste and olfaction identified by neurological evaluation during physical exam (screening visit).
- Positive pregnancy test, currently pregnant or breastfeeding.
- Hypoglycemic drug intake.
- Currently using medications known to inhibit taste response (GLP1 agonists).
- Currently experiencing temporary change/loss of taste and/or smell (individual may be rescreened when symptoms resolve).
- Persistent loss of taste and/or smell due to COVID-19 or other reason.
- NIAAA employees/staff or subordinates/relatives/co-workers of NIAAA employees/staff or study investigators.
- claustrophobia
- Ferromagnetic metal in the cranial cavity or eye, e.g., aneurysm clip implanted neural stimulator, cochlear implant, ocular foreign body.
- Presence of implanted cardiac pacemaker or auto-defibrillator.
- Individuals with an insulin pump.
- Presence of an irremovable body piercing.
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paule V Joseph, C.R.N.P.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 7, 2023
First Posted
January 10, 2023
Study Start
January 9, 2024
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
October 24, 2025
Record last verified: 2025-10-22